Osaic Holdings’s Adamas Pharmaceuticals ADMS Stock Holding History

Osaic Holdings’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,200	Closed	-$21K	–	7821
2021 Q3	$21K	Sell	4,200 -2,000	-32%	-$9.71K	﹤0.01%	5756
2021 Q2	$33K	Hold	6,200	–	–	﹤0.01%	5357
2021 Q1	$30K	Hold	6,200	–	–	﹤0.01%	5245
2020 Q4	$27K	Sell	6,200 -50	-0.8%	-$214	﹤0.01%	4985
2020 Q3	$26K	Hold	6,250	–	–	﹤0.01%	4769
2020 Q2	$16K	Hold	6,250	–	–	﹤0.01%	4942
2020 Q1	$18K	Buy	+6,250	New	+$28K	﹤0.01%	4716

Osaic Holdings's ADMS Position: Q4 2021 in Review

Osaic Holdings sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 4,200 shares — an estimated $21K sold.

Osaic Holdings first reported a position in ADMS in Q1 2020 and held it in 7 quarters. The position peaked at $33K in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Osaic Holdings reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Osaic Holdings sold 4,200 Adamas Pharmaceuticals shares in Q4 2021, an estimated $21K.
Osaic Holdings first reported a position in Adamas Pharmaceuticals in Q1 2020 and held it in 7 quarters.
Osaic Holdings's Adamas Pharmaceuticals position peaked at $33K in Q2 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.